First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive
In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent
FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX
ACS Modifies Pap Test Guidelines
Cancer Letter, PR Firm Settle Out Of Court On Copyright Violation
Comments Invited On Centers Program
Radiation Exposure Mostly Natural, NCRP Report Says
Trending Stories
- Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - Tom Sellers steps down as director of OHSU Knight, replaced by Lisa Coussens
Shivaani Kummar recently named interim CEO - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - In The Headlines: Private funding can’t replace federal funding—but it can help
- Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers